Stilen and Easyef awarded best new drugs from Korea Drug Research Association

Published: 2003-02-24 06:58:00

Updated: 2003-02-24 06:58:00

The Korea Drug Research Association announced it has selected Dong-A's Stillen and Daeoong's Easyef as the best R&D new drug awards and the award ceremony will be held through the KDRA's 17th regular general meeting on February 27.

The KDRA award is aimed at promoting the development of domest...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK